Quick answers
- What is Oseni?
- Oseni is a brand name of Alogliptin benzoate and pioglitazone hydrochloride, a prescription medicine. The FDA NDC Directory lists 4 Oseni products in 4 strengths and forms.
- Who makes Oseni?
- Takeda Pharms USA holds the FDA application for Oseni (NDA022426, approved January 25, 2013).
- Is there a generic or store brand of Oseni?
- Yes. The FDA NDC Directory lists 4 other products with the same active ingredients, strength and form as a Oseni product, 4 of them generic. Ask your pharmacist whether one is right for you.
- Has Oseni been recalled?
- No recall linked to Oseni products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Oseni is
Each Oseni product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Alogliptin benzoate and pioglitazone hydrochloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| alogliptin benzoate 12.5 mg · pioglitazone hydrochloride 30 mg tablet, film coated (oral) | Oseni | 1 product, 1 company | DailyMed |
| alogliptin benzoate 25 mg · pioglitazone hydrochloride 15 mg tablet, film coated (oral) | Oseni | 1 product, 1 company | DailyMed |
| alogliptin benzoate 25 mg · pioglitazone hydrochloride 30 mg tablet, film coated (oral) | Oseni | 1 product, 1 company | DailyMed |
| alogliptin benzoate 25 mg · pioglitazone hydrochloride 45 mg tablet, film coated (oral) | Oseni | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Alogliptin benzoate and pioglitazone hydrochloride →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA022426 | Takeda Pharms USA | January 25, 2013 | 4 |
Companies that list Oseni
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Oseni products.
- Takeda Pharmaceuticals America, Inc.4 products
Recalls
No recall linked to Oseni products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.